Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'
- PMID: 33589440
- DOI: 10.1136/annrheumdis-2021-219986
Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'
Keywords: COVID-19; qualitative research; therapeutics.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'' by Charles.Ann Rheum Dis. 2023 May;82(5):e109. doi: 10.1136/annrheumdis-2021-220001. Epub 2021 Feb 15. Ann Rheum Dis. 2023. PMID: 33589439 No abstract available.
-
Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'' by Charles.Ann Rheum Dis. 2023 May;82(5):e110. doi: 10.1136/annrheumdis-2021-220164. Epub 2021 Mar 3. Ann Rheum Dis. 2023. PMID: 33658235 No abstract available.
Comment on
-
Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study.Ann Rheum Dis. 2020 Sep;79(9):1143-1151. doi: 10.1136/annrheumdis-2020-218479. Epub 2020 Jul 20. Ann Rheum Dis. 2020. PMID: 32719045 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
